Search Results 1021-1030 of 18529 for Prednisone

1. Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis - Mayo Clinic

   However, patients may be on chronic steroids (maximum dose 20 mg/day prednisone or equivalent if they are being given for disorders other than amyloidosis ...

2. RA-PRO PRAGMATIC TRIAL - Mayo Clinic

   Glucocorticoid and NSAID treatment - If receiving glucocorticoids (≤ 10 mg/day of prednisone of equivalent) or NSAIDs, on stable doses for ≥ 2 weeks prior ...

3. A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung Cancer that has Returned or is Resistant to Treatment - Mayo Clinic

   Systemic therapy with corticosteroids at >20 mg/day prednisone or equivalent within 1 week prior to the first dose of study drug; History of another invasive ...

4. A Study to Evaluate the Effectiveness and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation - Mayo Clinic

   Use of prednisone or prednisolone > 30 mg/day or budesonide > 9 mg/day within 4 weeks prior to screening; or intravenous steroids within 4 weeks prior to ...

5. Dressler syndrome - Diagnosis and treatment - Mayo Clinic

   The exams includes listening to the heart with a device called a stethoscope. A sound called a pericardial rub can happen when the pericardium is inflamed or ...

6. Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years - Mayo Clinic

   - Frequent, repeated use of oral or parenteral glucocorticoids (e.g., prednisone, prednisolone, dexamethasone). Steroid inhalers and topical steroids may be ...

7. Update on the management of ANCA-associated vasculitis - Mayo Clinic

   ... prednisone daily. Trial results were published in the New England Journal of Medicine in 2017. For more information. Cartin-Ceba R, et al. Diffuse alveolar ...

8. Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF - Mayo Clinic

   Low dose corticosteroids ≤ 10 mg/day prednisone or equivalent is allowed for non-myelofibrosis purposes. Exclusion Criteria: Active, uncontrolled systemic ...

9. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

   For purposes of this trial, prednisone or other corticosteroids used for non-lymphomatous conditions will not be considered as prior chemotherapy. In ...

10. https://www.mayoclinic.org/arabic_procedure_concepts.xml